Stock Track | Quest Diagnostics Soars 5.09% Intraday After Q1 Earnings Beat and Raised Full-Year Guidance

Stock Track04-21

Shares of Quest Diagnostics (DGX) soared 5.09% during intraday trading on Tuesday, following the release of the company's first-quarter financial results.

The medical laboratory operator reported adjusted earnings per share of $2.50 for Q1 2026, beating the analyst consensus estimate of $2.35. Quarterly revenue of $2.90 billion also surpassed expectations of $2.83 billion. Driven by this strong performance, the company raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $10.63 to $10.83 and revenue between $11.78 billion and $11.90 billion.

The company cited resilient demand for routine diagnostic testing and double-digit revenue growth in its advanced diagnostics business, including blood tests for Alzheimer's disease, as key drivers behind the robust quarterly results and improved outlook.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1195136579?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-21 21:33","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1195136579","market":"us","top_or_hot":-1,"title":"Stock Track | Quest Diagnostics Soars 5.09% Intraday After Q1 Earnings Beat and Raised Full-Year Guidance","media":"Stock Track","content":"<p>Shares of Quest Diagnostics (DGX) soared 5.09% during intraday trading on Tuesday, following the release of the company's first-quarter financial results.</p><p>The medical laboratory operator reported adjusted earnings per share of $2.50 for Q1 2026, beating the analyst consensus estimate of $2.35. Quarterly revenue of $2.90 billion also surpassed expectations of $2.83 billion. Driven by this strong performance, the company raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $10.63 to $10.83 and revenue between $11.78 billion and $11.90 billion.</p><p>The company cited resilient demand for routine diagnostic testing and double-digit revenue growth in its advanced diagnostics business, including blood tests for Alzheimer's disease, as key drivers behind the robust quarterly results and improved outlook.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Quest Diagnostics Soars 5.09% Intraday After Q1 Earnings Beat and Raised Full-Year Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Quest Diagnostics Soars 5.09% Intraday After Q1 Earnings Beat and Raised Full-Year Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-21 21:33</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Quest Diagnostics (DGX) soared 5.09% during intraday trading on Tuesday, following the release of the company's first-quarter financial results.</p><p>The medical laboratory operator reported adjusted earnings per share of $2.50 for Q1 2026, beating the analyst consensus estimate of $2.35. Quarterly revenue of $2.90 billion also surpassed expectations of $2.83 billion. Driven by this strong performance, the company raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $10.63 to $10.83 and revenue between $11.78 billion and $11.90 billion.</p><p>The company cited resilient demand for routine diagnostic testing and double-digit revenue growth in its advanced diagnostics business, including blood tests for Alzheimer's disease, as key drivers behind the robust quarterly results and improved outlook.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DGX","symbol_name":"奎斯特诊疗","start_time":0,"source_url":"","article_id":"1195136579","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1195136579","pubTimestamp":1776778431,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Quest Diagnostics (DGX) soared 5.09% during intraday trading on Tuesday, following the release of the company's first-quarter financial results.The medical laboratory operator reported...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DGX":"奎斯特诊疗"},"translate_title":"个股追踪|Q1盈利超预期上调全年指引后Quest Diagnostics盘中大涨5.09%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DGX":1},"content_text":"Shares of Quest Diagnostics (DGX) soared 5.09% during intraday trading on Tuesday, following the release of the company's first-quarter financial results.The medical laboratory operator reported adjusted earnings per share of $2.50 for Q1 2026, beating the analyst consensus estimate of $2.35. Quarterly revenue of $2.90 billion also surpassed expectations of $2.83 billion. Driven by this strong performance, the company raised its full-year 2026 guidance, now expecting adjusted EPS in the range of $10.63 to $10.83 and revenue between $11.78 billion and $11.90 billion.The company cited resilient demand for routine diagnostic testing and double-digit revenue growth in its advanced diagnostics business, including blood tests for Alzheimer's disease, as key drivers behind the robust quarterly results and improved outlook.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1195136579","isCrawlerRequest":true}